Company profile · Leverkusen, Germany

Bayer Pharmaceuticals

Pharmaceutical Manufacturing and Therapeutic Platforms · Global commercial manufacturing

Verified 14 Mar 2026 · 3 sources

Commercial

Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview.

Contact & location
Website
bayer.com
LinkedIn
Company page
Lead
Bill Anderson (verified ↗)
Compliance
GMP Manufacturing
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Global commercial manufacturing
Capabilities
Commercial Therapeutics Manufacturing · Analytical Quality Control · Process Development and Formulation
Founded
1863
Headcount
10000+
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Bill Anderson

Chief Executive Officer

Check official leadership source
Full addressD-51368 Leverkusen, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Bayer supplier-information PDF identifying Bayer AG in D-51368 Leverkusen.

Open source
Operating profile

Global commercial manufacturing

Leverkusen, Germany. Pharmaceutical Manufacturing and Therapeutic Platforms. Review completed on 14 Mar 2026.

2026 technical specializationPharmaceutical Manufacturing and Therapeutic Platforms
Core capabilities
Commercial Therapeutics ManufacturingAnalytical Quality ControlProcess Development and Formulation
Governance

EMA, FDA, and global pharmaceutical oversight

GMP Manufacturing, Global Quality Management

Editorial note

Pharmaceutical Manufacturing and Therapeutic Platforms

Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview.

Related companies
Editorial note

Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Commercial Therapeutics Manufacturing
Analytical Quality Control
Process Development and Formulation
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceBayer leadership page confirming Bill Anderson as CEO.Source origin: bayer.comOpen source
Supporting evidenceBayer Pharmaceuticals at a glance page outlining the pharmaceutical operating footprint.Source origin: bayer.comOpen source
Physical-site evidenceOfficial Bayer supplier-information PDF identifying Bayer AG in D-51368 Leverkusen.Source origin: bayer.comOpen source
Infrastructure

Declared infrastructure

Drug-product manufacturing lines
Analytical quality laboratories
Formulation and process-development suites
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Bayer Pharmaceuticals located?
Bayer Pharmaceuticals operates from D-51368 Leverkusen, Germany, Leverkusen, Germany.
Who runs Bayer Pharmaceuticals?
Bayer Pharmaceuticals is led by Bill Anderson, Chief Executive Officer. Verified 14 Mar 2026.
What certifications does Bayer Pharmaceuticals hold?
Bayer Pharmaceuticals is documented under GMP Manufacturing.
What does Bayer Pharmaceuticals do?
Bayer joins the verified German core through its current leadership surface and live pharmaceutical operating overview. Core capabilities: Commercial Therapeutics Manufacturing, Analytical Quality Control, Process Development and Formulation.
Editorial context

Related technical briefs

Briefs that name Leverkusen as a covered market or city.